Ben Mullish
@bhmullish
Followers
1K
Following
4K
Media
78
Statuses
911
MRC Clinician Scientist Fellow and Honorary Consultant in Hepatology and Gastroenterology, based at Imperial College London. Tweets in a personal capacity.
London, England
Joined August 2012
RT @MGilchrist123: Operational considerations for the running of an NHS faecal microbiota transplant (FMT) service - we used an AMS approac….
0
1
0
Out now from us in @jhieditor - operational considerations in running an @NHSuk #FMT service: @ImperialMDR @IHepatology @BRCinfection.
0
5
7
RT @Biochem_Journal: Constipation is a forerunner to Parkinson’s disease diagnosis, worsening thereafter. New research from Umamahesan et a….
0
3
0
Very pleased to see this out in @CMIJournal - what non-antimicrobial options are there for recurrent #UTI, and what might be the role for #FMT? @rohmaghani @EdKuijper2 @ImperialMDR @BRCinfection.
clinicalmicrobiologyandinfection.org
Recurrent urinary tract infection (rUTI) is a common condition, affecting approximately one-third of women after an initial UTI. It significantly impacts health care costs and patients' quality of...
0
5
9
Great to see this work from Shiv Radhakrishnan and colleagues out in #GutMicrobes - using network analysis to explore #microbiome #metabolome interactions in an #IBD inception cohort: @IHepatology @ImperialMDR @KorcsmarosLab.
tandfonline.com
The gut microbiota contribute to the etiopathogenesis of inflammatory bowel disease (IBD), but limitations of prior studies include the use of sequencing alone (restricting exploration of the contr...
0
7
16
A great privilege to work with @JulieAKMcDonald lab @CBRB_Imperial on this new paper, now out in @NatureComms - how #antibiotic-related changes in gut #nutrients and #metabolites promote #VRE colonisation: @IHepatology @ImperialMDR @BRCinfection.
nature.com
Nature Communications - Here, the authors show that vancomycin-resistant enterococci grow in the antibiotic-treated gut microbiome by utilising enriched nutrients in the presence of reduced...
0
7
24
RT @2guystalkingit: Unravelling the gut microbiome with @bhmullish and @gianluca1aniro . We talk. #microbiome.#FMT.#microbiomemanupulation….
podcasts.apple.com
Podcast Episode · Two guys talking **it - A Gastroenterology and Hepatology podcast · 09/07/2025 · 1h 3m
0
8
0
RT @IHepatology: How common is #MASLD in those with chronic #HepB, and how does this impact #fibrosis and outcome? Results from a large Eu….
cghjournal.org
Chronic hepatitis B (CHB) and metabolic dysfunction-associated steatotic liver disease (MASLD) commonly co-exist, with conflicting data in prevalence and disease severity. We aimed to investigate...
0
3
0
RT @FrontGastro_BMJ: 🚨 New review alert! 🚨. Fantastic work @bhmullish and team on the complex area of MASLD 👏. What you will learn if you h….
0
14
0
RT @PROMISE_Trial: Another great month for PROMISE! Special thank you to Notts, Glasgow, SMH and KCH for randomising a total of 7 new patie….
0
1
0
Very pleased to see this out in @FrontGastro_BMJ, our update on diagnosis and staging in #MASLD: @penny_manousou @IHepatology @ImperialMDR @ForlanoRoberta.
fg.bmj.com
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide, with high morbidity and mortality rates. An early diagnosis, in primary care,...
0
10
22
Great to see this out in #JCEM @TheEndoSociety - the relationships between #MASLD, extrahepatic multimorbidity and all cause mortality in @uk_biobank: @ImperialMDR @IHepatology.
academic.oup.com
AbstractContext. Metabolic dysfunction–associated steatotic liver disease (MASLD) affects one third of the world's population, but its associations with ex
0
2
4
Glad that we are up and running in the @PROMISE_Trial at @IHepatology @ImperialMDR, and looking forward to exploring the impact of #FMT in #cirrhosis.
Big congrats to the @ImperialNHS team for recruiting you first PROMISE participant! 👏👏@bhmullish @MarkThursz #NIHRResearch #ClinicalTrials #FMT #ICL #StMarysHospital
1
5
19
And keeping an open mind about other therapeutic strategies, including vancomycin - read more about work by @NabilQuraishi and colleagues on this here:
Great work by @NabilQuraishi, @CholestasisDoc and many others - unravelling the positive impact of #vancomycin in #PSC #IBD by altering interactions between the host, #microbiome, and #metabolome. Now in @JCC_IBD: @IHepatology @ImperialMDR.
0
0
1
Well - for one - looking forward to the results of the FARGO trial @CholestasisDoc @PSCSupportUK :
Pleased that #FARGO - a randomised, multicentre, placebo-controlled phase IIa trial of #FMT to treat #PSC - is running and recruiting. Have a look at the protocol paper out now in @BMJ_Open: @lifearc1 @PSCSupportUK @CholestasisDoc @ImperialMDR.
1
3
5
Honoured to be part of this Future of Hepatology session at #EASL2025, discussing the promise of #microbiome related therapies in #PSC #cholestatic liver disease - where have we come since the original #FMT #PSC pilot study by @DrAllegrettiIBD: 10.14309/ajg.0000000000000115
1
5
22
Want to know more about why we are looking at the #GutMicrobiome #IMT #HCT as therapy? Find out even more here:
0
0
1
The #MAST trial is pushing forward, investigating the impact of #IMT #FMT prior to #HCT in seven UK centres. Find out more from our poster or our website: @IHepatology @ImperialMDR @bloodcancer_uk @AnthonyNolan
1
5
16
A great first day at the @BritSocGastro #GutMicrobiome event in Edinburgh, covering everything from early life @hall_lab, to #liver @DebbieShawcros1, to #cancer @bowelsurgeon, and culminating in a tour de force on #IBD and the #microbiome in clinical practice from @h_sokol
1
4
30